264 related articles for article (PubMed ID: 9597987)
1. Donepezil for Alzheimer's disease.
Sparano N
J Fam Pract; 1998 May; 46(5):356. PubMed ID: 9597987
[No Abstract] [Full Text] [Related]
2. Donepezil for Alzheimer's disease?
Drug Ther Bull; 1997 Oct; 35(10):75-6. PubMed ID: 9489056
[No Abstract] [Full Text] [Related]
3. Is donepezil effective for treating Alzheimer's disease?
Steele LS; Glazier RH
Can Fam Physician; 1999 Apr; 45():917-9. PubMed ID: 10216789
[No Abstract] [Full Text] [Related]
4. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
[No Abstract] [Full Text] [Related]
5. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
[TBL] [Abstract][Full Text] [Related]
9. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699
[TBL] [Abstract][Full Text] [Related]
10. Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?
Tinklenberg JR; Kraemer HC; Yaffe K; Ross L; Sheikh J; Ashford JW; Yesavage JA; Taylor JL
Am J Geriatr Psychiatry; 2007 Nov; 15(11):953-60. PubMed ID: 17974866
[TBL] [Abstract][Full Text] [Related]
11. Continuing donepezil produces cognitive benefits in Alzheimer's.
Bland P
Practitioner; 2012 Apr; 256(1750):5. PubMed ID: 22792683
[No Abstract] [Full Text] [Related]
12. Donepezil (Aricept) for Alzheimer's disease.
Med Lett Drugs Ther; 1997 Jun; 39(1002):53-4. PubMed ID: 9187642
[No Abstract] [Full Text] [Related]
13. Donepezil and Alzheimer's dementia.
Earl-Slater A; Walley T
Clin Perform Qual Health Care; 2000; 8(1):47-51. PubMed ID: 11183967
[No Abstract] [Full Text] [Related]
14. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
Stiles MM; Martin S; Persons RK
J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
[No Abstract] [Full Text] [Related]
15. Donepezil (Aricept) therapy for Alzheimer's disease.
Geldmacher DS
Compr Ther; 1997 Jul; 23(7):492-3. PubMed ID: 9262925
[No Abstract] [Full Text] [Related]
16. Does donepezil improve well-being for dementia due to Alzheimer's disease?
Birks J
Neuroepidemiology; 2005; 24(3):168-9. PubMed ID: 15677877
[No Abstract] [Full Text] [Related]
17. Donepezil minimally effective for patients with vascular dementia.
Johnson KD
J Fam Pract; 2004 Mar; 53(3):181-2. PubMed ID: 15000918
[No Abstract] [Full Text] [Related]
18. Switching from donepezil to galantamine: a double-blind study of two wash-out periods.
Wilkinson DG; Howe I
Int J Geriatr Psychiatry; 2005 May; 20(5):489-91. PubMed ID: 15852437
[No Abstract] [Full Text] [Related]
19. A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease.
Burns A; Perry E; Holmes C; Francis P; Morris J; Howes MJ; Chazot P; Lees G; Ballard C
Dement Geriatr Cogn Disord; 2011; 31(2):158-64. PubMed ID: 21335973
[TBL] [Abstract][Full Text] [Related]
20. Donepezil treatment in Alzheimer's disease patients with and without cerebrovascular lesions: a preliminary report.
Na HR; Kim S; Choi SH; Yang DW; Bae HJ; Kim JE; Park MY; Shim YS; Kim BK; Kwon JC; Yoo BG; Kim BC; Lee JS
Geriatr Gerontol Int; 2011 Jan; 11(1):90-7. PubMed ID: 20825496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
